Research and development
Flow – sum over the period · $M
Q4 FY2025
79.5a$M
derived
All values (44)
| Period | Value ($M) | Status |
|---|---|---|
| Q4 FY2026 | 104.4 | derived |
| Q3 FY2026 | 90.6 | reported |
| Q2 FY2026 | 80.1 | reported |
| Q1 FY2026 | 81.4 | reported |
| Q4 FY2025 | 79.5 | derived |
| Q3 FY2025 | 75.9 | reported |
| Q2 FY2025 | 74.2 | reported |
| Q1 FY2025 | 74.3 | reported |
| Q4 FY2024 | 73.2 | derived |
| Q3 FY2024 | 77.2 | reported |
| Q2 FY2024 | 78.3 | reported |
| Q1 FY2024 | 73.5 | reported |
| Q4 FY2023 | 73.9 | derived |
| Q3 FY2023 | 85.4 | reported |
| Q2 FY2023 | 75.8 | reported |
| Q1 FY2023 | 72.7 | reported |
| Q4 FY2022 | 56.7 | derived |
| Q3 FY2022 | 56.7 | reported |
| Q2 FY2022 | 53.2 | reported |
| Q1 FY2022 | 54.1 | reported |
| Q4 FY2021 | 54.1 | reported |
| Q3 FY2021 | 57.2 | reported |
| Q2 FY2021 | 52.8 | reported |
| Q1 FY2021 | 50.4 | reported |
| Q4 FY2020 | 49.0 | reported |
| Q3 FY2020 | 48.7 | reported |
| Q2 FY2020 | 51.0 | reported |
| Q1 FY2020 | 49.9 | reported |
| Q4 FY2019 | 49.5 | reported |
| Q3 FY2019 | 57.7 | reported |
| Q2 FY2019 | 42.8 | reported |
| Q1 FY2019 | 34.6 | reported |
| Q4 FY2018 | 38.5 | reported |
| Q3 FY2018 | 38.2 | reported |
| Q2 FY2018 | 43.8 | reported |
| Q1 FY2018 | 36.3 | reported |
| Q4 FY2017 | 35.4 | reported |
| Q3 FY2017 | 37.3 | reported |
| Q2 FY2017 | 38.7 | reported |
| Q1 FY2017 | 36.9 | reported |
| Q4 FY2016 | 36.4 | reported |
| Q3 FY2016 | 35.3 | reported |
| Q2 FY2016 | 35.0 | reported |
| Q1 FY2016 | 34.4 | reported |
CSV with all sources · Technical ID: rnd
More metrics for Lumentum
Income statement
Balance sheet
Debt and interest
Revenue by segment/product/region
Sources & calculation
- Value
- $80.0M (derived)
- Period
- Q4 FY2025, ended Jun 28, 2025 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 304M − 224M = $80.0M (FY value from 10-K 0001628280-26-057358; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Aug 17, 2026 · 0001628280-26-057358
- Location
- us-gaap:ResearchAndDevelopmentExpense
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $80.0M | Aug 17, 2026 | 10-K 0001628280-26-057358 | derived · confidence 1. · current |